Evidence map›Paper›PMID 34513285›Full record

ArticleAmerican journal of nuclear medicine and molecular imaging2021

Heuristic scoring method utilizing FDG-PET statistical parametric mapping in the evaluation of suspected Alzheimer disease and frontotemporal lobar degeneration.

Jeremy N Ford, Elizabeth M Sweeney, Myrto Skafida, Shannon Glynn, Michael Amoashiy, Dale J Lange, Eaton Lin, Gloria C Chiang, Joseph R Osborne, Silky Pahlajani and 2 more

Open access · greenAbstract read
In one paragraph

Article in American journal of nuclear medicine and molecular imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Jeremy N FordDepartment of Radiology, Massachusetts General Hospital Boston, MA, United States.
Elizabeth M SweeneyDepartment of Population Health Sciences, Division of Biostatistics and Epidemiology, Weill Cornell Medical College New York, NY, United States.
Myrto SkafidaDepartment of Radiology, Weill Cornell Medical College New York, NY, United States.
Shannon GlynnDepartment of Radiology, Weill Cornell Medical College New York, NY, United States.
Michael AmoashiyDepartment of Neurology, Weill Cornell Medical College New York, NY, United States.
Dale J LangeDepartment of Neurology, Hospital for Special Surgery New York, NY, United States.
Eaton LinDepartment of Radiology, Weill Cornell Medical College New York, NY, United States.
Gloria C ChiangDepartment of Radiology, Weill Cornell Medical College New York, NY, United States.
Joseph R OsborneDepartment of Radiology, Weill Cornell Medical College New York, NY, United States.
Silky PahlajaniDepartment of Neurology, Weill Cornell Medical College New York, NY, United States.
Mony J de LeonDepartment of Radiology, Weill Cornell Medical College New York, NY, United States.
Jana IvanidzeDepartment of Radiology, Weill Cornell Medical College New York, NY, United States.
Cornell University · USHospital for Special Surgery · USMassachusetts General Hospital · US

Funding

Research Education ComponentP30AG066512 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Mary Sherman Mittelman · 2020 to 2026
$28.4M
PET Measures of CSF Clearance in Preclinical Alzheimer's DiseaseRF1AG057570 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · PI DE LEON, MONY J. · 2017 to 2017
$4.1M
The effects of iron on oxidative stress and Alzheimer's biomarkers in amyloid-positive and negative elderly normalR01AG068398 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · PI CHIANG, GLORIA CHIA-YI · 2020 to 2024
$2.8M
CSF Clearance with 11C-Butanol PET Predicts Amyloid DepositionR56AG058913 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · PI DE LEON, MONY J., RUSINEK, HENRY · 2018 to 2018
$861k
NIA NIH HHS P30 AG066512NIA NIH HHS R01 AG068398NIA NIH HHS R56 AG058913NIA NIH HHS RF1 AG057570
6 · The paper itself

Abstract

Distinguishing frontotemporal lobar degeneration (FTLD) and Alzheimer Disease (AD) on FDG-PET based on qualitative review alone can pose a diagnostic challenge. SPM has been shown to improve diagnostic performance in research settings, but translation to clinical practice has been lacking. Our purpose was to create a heuristic scoring method based on statistical parametric mapping z-scores. We aimed to compare the performance of the scoring method to the initial qualitative read and a machine learning (ML)-based method as benchmarks. FDG-PET/CT or PET/MRI of 65 patients with suspected dementia were processed using SPM software, yielding z-scores from either whole brain (W) or cerebellar (C) normalization relative to a healthy cohort. A non-ML, heuristic scoring system was applied using region counts below a preset z-score cutoff. W z-scores, C z-scores, or WC z-scores (z-scores from both W and C normalization) served as features to build random forest models. The neurological diagnosis was used as the gold standard. The sensitivity of the non-ML scoring system and the random forest models to detect AD was higher than the initial qualitative read of the standard FDG-PET [0.89-1.00 vs. 0.22 (95% CI, 0-0.33)]. A categorical random forest model to distinguish AD, FTLD, and normal cases had similar accuracy than the non-ML scoring model (0.63 vs. 0.61). Our non-ML-based scoring system of SPM z-scores approximated the diagnostic performance of a ML-based method and demonstrated higher sensitivity in the detection of AD compared to qualitative reads. This approach may improve the diagnostic performance.

Indexed as

AlzheimerDementiaFDG-PETFTLDSPM

Identifiers

PMID34513285
PMCPMC8414399
OpenAlexW3199407808

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.